Tech Company Financing Transactions

Egle Therapeutics Funding Round

Egle Therapeutics, based in Paris, secured $46.4 million from Bpifrance, LSP BioVentures and Bioqube Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

29 Rue du Faubourg St Jacques Pépinière Cochin Paris Santé
Paris, 75014
France

Phone

+33-186640857

Website

www.egle-tx.com

Email Address

[email protected]

Overview

Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs' starving while specifically targeting the most immunosuppressive ones.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Luc Boblet

        

Chief Financial Officer

Stéphane Postic

        

Browse more venture capital transactions:

Prev: 10/26/2021: Cedilla Therapeutics venture capital transaction
Next: 10/26/2021: Justos venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary